--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
Tesla
TSLA
NVIDIA
NVDA
Palantir
PLTR
4
Apple
AAPL
5
Strategy
MSTR
US Stock MarketDetailed Quotes
CNTX Context Therapeutics
- 0.7600
- -0.0045-0.59%
Trading Mar 11 09:53 ET
68.18MMarket Cap-0.86P/E (TTM)
0.7645High0.7300Low2.62KVolume0.7645Open0.7645Pre Close1.97KTurnover0.01%Turnover RatioLossP/E (Static)89.70MShares2.750052wk High0.81P/B30.20MFloat Cap0.730052wk Low--Dividend TTM39.74MShs Float10.8700Historical High--Div YieldTTM4.51%Amplitude0.4700Historical Low0.7490Avg Price1Lot Size
Context Therapeutics Key Stats
Context Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Context Therapeutics Earnings Reports
Read more